Myomo, Inc. (MYO)
After hours:
| Previous close | 3.9200 |
| Open | 3.9500 |
| Bid | 3.7600 x 1000 |
| Ask | 3.8400 x 1000 |
| Day's range | 3.6500 - 4.1900 |
| 52-week range | 0.3710 - 5.5800 |
| Volume | |
| Avg. volume | 272,788 |
| Market cap | 108.286M |
| Beta (5Y monthly) | 1.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Myomo to Report First Quarter Financial Results on May 8, 2024
BOSTON, May 01, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2024 on May 8, 2024.
- Business Wire
Myomo Appoints Heather Getz to its Board of Directors
BOSTON, March 28, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors.
- Business Wire
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
BOSTON, March 07, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months and year ended December 31, 2023.
